Assenagon Asset Management S.A. - DECIPHERA PHARMACEUTICALS IN ownership

DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 157 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.

Quarter-by-quarter ownership
Assenagon Asset Management S.A. ownership history of DECIPHERA PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$10,302,221
-13.8%
809,923
-4.6%
0.03%
-22.0%
Q2 2023$11,948,739
-8.9%
848,6320.0%0.04%
-12.8%
Q1 2023$13,111,364
+78628.0%
848,632
-16.5%
0.05%
-21.7%
Q4 2022$16,654
-99.9%
1,016,079
-27.6%
0.06%
-40.0%
Q3 2022$25,971,000
+180.3%
1,403,821
+99.2%
0.10%
+194.1%
Q2 2022$9,267,000
+16.8%
704,750
-17.6%
0.03%
+54.5%
Q1 2022$7,932,000
+232.3%
855,699
+250.2%
0.02%
+214.3%
Q4 2021$2,387,000
+186.9%
244,365
+897.8%
0.01%
+133.3%
Q3 2021$832,000
-12.5%
24,491
-5.7%
0.00%0.0%
Q2 2021$951,00025,9740.00%
Other shareholders
DECIPHERA PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 1,209,571$15,385,74319.76%
Redmile Group, LLC 4,475,384$56,926,8842.71%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 6,897,606$87,737,5481.93%
Parkman Healthcare Partners LLC 597,403$7,598,9661.39%
Ghost Tree Capital, LLC 325,000$4,134,0001.36%
BRAIDWELL LP 3,336,221$42,436,7311.34%
AlphaCentric Advisors LLC 132,000$1,679,0400.95%
ARMISTICE CAPITAL, LLC 4,612,000$58,664,6400.90%
Sunesis Advisors, LLC 96,299$1,224,9230.87%
EcoR1 Capital, LLC 993,000$12,630,9600.43%
View complete list of DECIPHERA PHARMACEUTICALS IN shareholders